PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $282,000 | -33.0% | 67,200 | 0.0% | 0.01% | -10.0% |
Q3 2018 | $421,000 | -22.0% | 67,200 | 0.0% | 0.01% | -28.6% |
Q2 2018 | $540,000 | +7.8% | 67,200 | 0.0% | 0.01% | -6.7% |
Q1 2018 | $501,000 | +25.2% | 67,200 | 0.0% | 0.02% | +25.0% |
Q4 2017 | $400,000 | -19.2% | 67,200 | 0.0% | 0.01% | -20.0% |
Q3 2017 | $495,000 | +8.6% | 67,200 | -0.1% | 0.02% | 0.0% |
Q2 2017 | $456,000 | -28.2% | 67,260 | 0.0% | 0.02% | -25.0% |
Q1 2017 | $635,000 | +9.3% | 67,260 | +0.1% | 0.02% | +5.3% |
Q4 2016 | $581,000 | +36.7% | 67,200 | 0.0% | 0.02% | +58.3% |
Q3 2016 | $425,000 | +49.6% | 67,200 | 0.0% | 0.01% | +71.4% |
Q2 2016 | $284,000 | -3.1% | 67,200 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $293,000 | -28.9% | 67,200 | 0.0% | 0.01% | -22.2% |
Q4 2015 | $412,000 | +7.3% | 67,200 | 0.0% | 0.01% | +28.6% |
Q3 2015 | $384,000 | -23.4% | 67,200 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $501,000 | +24.6% | 67,200 | 0.0% | 0.01% | +16.7% |
Q1 2015 | $402,000 | -20.9% | 67,200 | 0.0% | 0.01% | -14.3% |
Q4 2014 | $508,000 | +45.6% | 67,200 | 0.0% | 0.01% | +75.0% |
Q3 2014 | $349,000 | +20.3% | 67,200 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $290,000 | +5.5% | 67,200 | 0.0% | 0.00% | +33.3% |
Q1 2014 | $275,000 | -23.2% | 67,200 | 0.0% | 0.00% | -40.0% |
Q4 2013 | $358,000 | +6.2% | 67,200 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $337,000 | +12.3% | 67,200 | 0.0% | 0.01% | +25.0% |
Q2 2013 | $300,000 | – | 67,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|